Publications found:
58,333
Sort by:
Hospital Acquired Pneumonia (HAP) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF HOSPITAL ACQUIRED PNEUMONIA (HAP) PIPELINE REPORT INCLUDES Panorama of Hospital Acquired Pneumonia (HAP) pipeline markets including statistics on therapeutic drugs and companies involved Hospital Acquired Pneumonia (HAP) Pipeline candidates across ...
August 2018
120 pages
Hot Flashes R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HOT FLASHES PIPELINE REPORT INCLUDES Panorama of Hot Flashes pipeline markets including statistics on therapeutic drugs and companies involved Hot Flashes Pipeline candidates across various development ...
August 2018
50 pages
House Dust Mite Allergy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF HOUSE DUST MITE ALLERGY PIPELINE REPORT INCLUDES Panorama of House Dust Mite Allergy pipeline markets including statistics on therapeutic drugs and companies involved House Dust Mite Allergy Pipeline candidates across ...
August 2018
40 pages
Human Parainfluenza Virus 3 Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF HUMAN PARAINFLUENZA VIRUS 3 INFECTIONS PIPELINE REPORT INCLUDES Panorama of Human Parainfluenza Virus 3 Infections pipeline markets including statistics on therapeutic drugs and companies involved Human Parainfluenza Virus 3 Infections Pipeline candidates across ...
August 2018
30 pages
Hyperalgesia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERALGESIA PIPELINE REPORT INCLUDES Panorama of Hyperalgesia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Hypercholesterolemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERCHOLESTEROLEMIA PIPELINE REPORT INCLUDES Panorama of Hypercholesterolemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
160 pages
Hypereosinophilic Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HYPEREOSINOPHILIC SYNDROME PIPELINE REPORT INCLUDES Panorama of Hypereosinophilic Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Hypereosinophilic Syndrome Pipeline candidates across various development ...
August 2018
50 pages
Hyperglycemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERGLYCEMIA PIPELINE REPORT INCLUDES Panorama of Hyperglycemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
20 pages
Hyperinsulinemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERINSULINEMIA PIPELINE REPORT INCLUDES Panorama of Hyperinsulinemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Hyperlipidemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERLIPIDEMIA PIPELINE REPORT INCLUDES Panorama of Hyperlipidemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
170 pages
Hyperoxaluria R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HYPEROXALURIA PIPELINE REPORT INCLUDES Panorama of Hyperoxaluria pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Hyperphosphatemia In Chronic Kidney Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE PIPELINE REPORT INCLUDES Panorama of Hyperphosphatemia In Chronic Kidney Disease pipeline markets including statistics on therapeutic drugs and companies involved Hyperphosphatemia In Chronic Kidney Disease Pipeline candidates across ...
August 2018
40 pages
Hypertriglyceridemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERTRIGLYCERIDEMIA PIPELINE REPORT INCLUDES Panorama of Hypertriglyceridemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
90 pages
Hypertrophic Cardiomyopathy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HYPERTROPHIC CARDIOMYOPATHY PIPELINE REPORT INCLUDES Panorama of Hypertrophic Cardiomyopathy pipeline markets including statistics on therapeutic drugs and companies involved Hypertrophic Cardiomyopathy Pipeline candidates across various development ...
August 2018
40 pages
Hyperuricemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERURICEMIA PIPELINE REPORT INCLUDES Panorama of Hyperuricemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Hypoglycemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HYPOGLYCEMIA PIPELINE REPORT INCLUDES Panorama of Hypoglycemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Hypogonadotropic Hypogonadism (HH) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HYPOGONADOTROPIC HYPOGONADISM (HH) PIPELINE REPORT INCLUDES Panorama of Hypogonadotropic Hypogonadism (HH) pipeline markets including statistics on therapeutic drugs and companies involved Hypogonadotropic Hypogonadism (HH) Pipeline candidates across various development ...
August 2018
50 pages
Hypoparathyroidism R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HYPOPARATHYROIDISM PIPELINE REPORT INCLUDES Panorama of Hypoparathyroidism pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Hypopharyngeal Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HYPOPHARYNGEAL CANCER PIPELINE REPORT INCLUDES Panorama of Hypopharyngeal Cancer pipeline markets including statistics on therapeutic drugs and companies involved Hypopharyngeal Cancer Pipeline candidates across various development ...
August 2018
110 pages
Hypotension R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HYPOTENSION PIPELINE REPORT INCLUDES Panorama of Hypotension pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Hypothyroidism R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HYPOTHYROIDISM PIPELINE REPORT INCLUDES Panorama of Hypothyroidism pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
20 pages
Idiopathic Hypertension R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF IDIOPATHIC HYPERTENSION PIPELINE REPORT INCLUDES Panorama of Idiopathic Hypertension pipeline markets including statistics on therapeutic drugs and companies involved Idiopathic Hypertension Pipeline candidates across various development ...
August 2018
50 pages
Idiopathic Thrombocytopenic Purpura R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF IDIOPATHIC THROMBOCYTOPENIC PURPURA PIPELINE REPORT INCLUDES Panorama of Idiopathic Thrombocytopenic Purpura pipeline markets including statistics on therapeutic drugs and companies involved Idiopathic Thrombocytopenic Purpura Pipeline candidates across various development ...
August 2018
90 pages
Impetigo R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF IMPETIGO PIPELINE REPORT INCLUDES Panorama of Impetigo pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Inclusion Body Myositis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF INCLUSION BODY MYOSITIS PIPELINE REPORT INCLUDES Panorama of Inclusion Body Myositis pipeline markets including statistics on therapeutic drugs and companies involved Inclusion Body Myositis Pipeline candidates across various development ...
August 2018
50 pages
Indolent Lymphoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF INDOLENT LYMPHOMA PIPELINE REPORT INCLUDES Panorama of Indolent Lymphoma pipeline markets including statistics on therapeutic drugs and companies involved Indolent Lymphoma Pipeline candidates across various development ...
August 2018
170 pages
Infantile Spasm (West Syndrome) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF INFANTILE SPASM (WEST SYNDROME) PIPELINE REPORT INCLUDES Panorama of Infantile Spasm (West Syndrome) pipeline markets including statistics on therapeutic drugs and companies involved Infantile Spasm (West Syndrome) Pipeline candidates across ...
August 2018
50 pages
Influenza B Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF INFLUENZA B INFECTIONS PIPELINE REPORT INCLUDES Panorama of Influenza B Infections pipeline markets including statistics on therapeutic drugs and companies involved Influenza B Infections Pipeline candidates across various development ...
August 2018
60 pages
Influenzavirus B Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF INFLUENZAVIRUS B INFECTIONS PIPELINE REPORT INCLUDES Panorama of Influenzavirus B Infections pipeline markets including statistics on therapeutic drugs and companies involved Influenzavirus B Infections Pipeline candidates across various development ...
August 2018
100 pages
Insomnia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF INSOMNIA PIPELINE REPORT INCLUDES Panorama of Insomnia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
90 pages
Insulin Resistance R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF INSULIN RESISTANCE PIPELINE REPORT INCLUDES Panorama of Insulin Resistance pipeline markets including statistics on therapeutic drugs and companies involved Insulin Resistance Pipeline candidates across various development ...
August 2018
40 pages
Intermittent Claudication R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF INTERMITTENT CLAUDICATION PIPELINE REPORT INCLUDES Panorama of Intermittent Claudication pipeline markets including statistics on therapeutic drugs and companies involved Intermittent Claudication Pipeline candidates across various development ...
August 2018
40 pages
Interstitial Cystitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF INTERSTITIAL CYSTITIS PIPELINE REPORT INCLUDES Panorama of Interstitial Cystitis pipeline markets including statistics on therapeutic drugs and companies involved Interstitial Cystitis Pipeline candidates across various development ...
August 2018
70 pages
Iron Deficiency Anemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF IRON DEFICIENCY ANEMIA PIPELINE REPORT INCLUDES Panorama of Iron Deficiency Anemia pipeline markets including statistics on therapeutic drugs and companies involved Iron Deficiency Anemia Pipeline candidates across various development ...
August 2018
60 pages
Irritable Bowel Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF IRRITABLE BOWEL SYNDROME PIPELINE REPORT INCLUDES Panorama of Irritable Bowel Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Irritable Bowel Syndrome Pipeline candidates across various development ...
August 2018
120 pages
Ischemia Reperfusion Injury R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF ISCHEMIA REPERFUSION INJURY PIPELINE REPORT INCLUDES Panorama of Ischemia Reperfusion Injury pipeline markets including statistics on therapeutic drugs and companies involved Ischemia Reperfusion Injury Pipeline candidates across various development ...
August 2018
130 pages
Japanese Encephalitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF JAPANESE ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Japanese Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved Japanese Encephalitis Pipeline candidates across various development ...
August 2018
40 pages
Juvenile Macular Degeneration (Stargardt Disease) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... use format. SCOPE OF JUVENILE MACULAR DEGENERATION (STARGARDT DISEASE) PIPELINE REPORT INCLUDES Panorama of Juvenile Macular Degeneration (Stargardt Disease) pipeline markets including statistics on therapeutic drugs and companies involved Juvenile Macular Degeneration (Stargardt Disease) Pipeline candidates ...
August 2018
60 pages
Kaposi Sarcoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF KAPOSI SARCOMA PIPELINE REPORT INCLUDES Panorama of Kaposi Sarcoma pipeline markets including statistics on therapeutic drugs and companies involved Kaposi Sarcoma Pipeline candidates across various development ...
August 2018
180 pages
Keloids R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF KELOIDS PIPELINE REPORT INCLUDES Panorama of Keloids pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Kennedy’s Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF KENNEDY’S DISEASE PIPELINE REPORT INCLUDES Panorama of Kennedy’s Disease pipeline markets including statistics on therapeutic drugs and companies involved Kennedy’s Disease Pipeline candidates across various development ...
August 2018
20 pages
Keratitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF KERATITIS PIPELINE REPORT INCLUDES Panorama of Keratitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Kidney Fibrosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF KIDNEY FIBROSIS PIPELINE REPORT INCLUDES Panorama of Kidney Fibrosis pipeline markets including statistics on therapeutic drugs and companies involved Kidney Fibrosis Pipeline candidates across various development ...
August 2018
110 pages
Kidney Transplant Rejection R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF KIDNEY TRANSPLANT REJECTION PIPELINE REPORT INCLUDES Panorama of Kidney Transplant Rejection pipeline markets including statistics on therapeutic drugs and companies involved Kidney Transplant Rejection Pipeline candidates across various development ...
August 2018
130 pages
Klebsiella pneumoniae Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE REPORT INCLUDES Panorama of Klebsiella pneumoniae Infections pipeline markets including statistics on therapeutic drugs and companies involved Klebsiella pneumoniae Infections Pipeline candidates across various development ...
August 2018
90 pages
Lassa Fever (Lassa Hemorrhagic Fever) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF LASSA FEVER (LASSA HEMORRHAGIC FEVER) PIPELINE REPORT INCLUDES Panorama of Lassa Fever (Lassa Hemorrhagic Fever) pipeline markets including statistics on therapeutic drugs and companies involved Lassa Fever (Lassa Hemorrhagic Fever) Pipeline candidates across ...
August 2018
40 pages
Leber Congenital Amaurosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF LEBER CONGENITAL AMAUROSIS PIPELINE REPORT INCLUDES Panorama of Leber Congenital Amaurosis pipeline markets including statistics on therapeutic drugs and companies involved Leber Congenital Amaurosis Pipeline candidates across various development ...
August 2018
50 pages
Leber’s Hereditary Optic Neuropathy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF LEBER’S HEREDITARY OPTIC NEUROPATHY PIPELINE REPORT INCLUDES Panorama of Leber’s Hereditary Optic Neuropathy pipeline markets including statistics on therapeutic drugs and companies involved Leber’s Hereditary Optic Neuropathy Pipeline candidates across ...
August 2018
50 pages
Left Ventricular Dysfunction R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF LEFT VENTRICULAR DYSFUNCTION PIPELINE REPORT INCLUDES Panorama of Left Ventricular Dysfunction pipeline markets including statistics on therapeutic drugs and companies involved Left Ventricular Dysfunction Pipeline candidates across various development ...
August 2018
40 pages
